Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways

Molecules and Cells

Volumn 33, Issue 2, 2012, Pages 127-133

  Kim, Ju Hee ^a   Kang, Seongeun ^a   Kim, Tae Woo ^a   Yin, Lihong ^b   Liu, Ran ^b   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

5 Aza 2' deoxycytidine; Breast cancer; Genome wide expression; MCF 7; TNF

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL STRAIN MCF 7; DEMETHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; HUMAN; HUMAN CELL; UPREGULATION;

AZA COMPOUNDS; BREAST NEOPLASMS; CARCINOGENS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863448344     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-2182-8     Document Type: Article

References (37)

1. Ando, K., Kanazawa, S., Tetsuka, T., Ohta, S., Jiang, X., Tada, T., Kobayashi, M., Matsui, N., and Okamoto, T. (2003). Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene 22, 7796-7803. (Pubitemid 37485538)
2. Bonazzi, V. F., Irwin, D., and Hayward, N. K. (2009). Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer 48, 10-21.
3. Budinsky, A. C., Brodowicz, T., Wiltschke, C., Czerwenka, K., Michl, I., Krainer, M., and Zielinski, C. C. (1997). Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breastcancer cells in vitro. Int. J. Cancer 71, 1086-1090. (Pubitemid 27252894)
4. Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., Tschoeke, S. K., et al. (2005). A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037. (Pubitemid 41486985)
5. Chambers, A. F., and Goss, P. E. (2008). Putative growth characteristics of micrometastatic breast cancer. Breast Cancer Res. 10, 114.
6. Dempsey, P. W., Doyle, S. E., He, J. Q., and Cheng, G. (2003). The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14, 193-209. (Pubitemid 36693141)
7. Kim, T. W., Kim, Y. J., Lee, H. J., Min, S. Y., Kang, H. S., and Kim, S. J. (2010). Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer. Int. J. Oncol. 36, 1105-1111.
8. Kim, S. J., Kelly, W. K., Fu, A., Haines, K., Hoffman, A., Zheng, T., and Zhu, Y. (2011). Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer. Cancer Lett. 302, 47-53.
9. Kulis, M., and Esteller, M. (2010). DNA methylation and cancer. Adv. Genet. 70, 27-56.
10. Kwon, M. S., Kim, S. J., Lee, S. Y., Jeong, J. H., Lee, E. S., and Kang, H. S. (2006). Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue. Oncol. Rep. 15, 27-32.
11. Laux, D. E., Curran, E. M., Welshons, W. V., Lubahn, D. B., and Huang, T. H. (1999). Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res. Treat. 56, 35-43. (Pubitemid 29435813)
12. Li, L., Lee, K. M., Han, W., Choi, J. Y., Lee, J. Y., Kang, G. H., Park, S. K., Noh, D. Y., Yoo, K. Y., and Kang, D. (2010). Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer. Hum. Mol. Genet. 19, 4273-4277.
13. Liu, B., Tahk, S., Yee, K. M., Fan, G., and Shuai, K. (2010). The ligase PIAS1 restricts natural regulatory T cell differentiation by epigenetic repression. Science 330, 521-525.
14. Lu, L., Katsaros, D., de la Longrais, I. A., Sochirca, O., and Yu, H. (2007). Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67, 10117-10122. (Pubitemid 350070782)
15. Lui, E. L., Loo, W. T., Zhu, L., Cheung, M. N., and Chow, L. W. (2005). DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma. Biomed. Pharmacother. 59 Suppl. 2, S363-365.
16. Maegawa, S., Hinkal, G., Kim, H. S., Shen, L., Zhang, L., Zhang, J., Zhang, N., Liang, S., Donehower, L. A., and Issa, J. P. (2010). Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 20, 332-340.
17. Malumbres, M., Pérez de Castro, I., Santos, J., Fernández Piqueras, J., and Pellicer, A. (1999). Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene 18, 385-396. (Pubitemid 29060614)
18. Matros, E., Wang, Z. C., Lodeiro, G., Miron, A., Iglehart, J. D., and Richardson, A. L. (2005). BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res. Treat. 91, 179-186. (Pubitemid 40684930)
19. Politi, K., Feirt, N., and Kitajewski, J. (2004). Notch in mammary gland development and breast cancer. Semin. Cancer Biol. 14, 341-347. (Pubitemid 38993635)
20. Rivenbark, A. G., Jones, W. D., Risher, J. D., and Coleman, W. B. (2006). DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells. Epigenetics 1, 32-44.
21. Rodenhiser, D., Andrews, J., Kennette, W., Sadikovic, B., Mendlowitz, A., Tuck, A., and Chambers, A. (2008a). Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res. 10, R62.
22. Rodenhiser, D. I., Andrews, J., Kennette, W., Sadikovic, B., Mendlowitz, A., Tuck, A. B., and Chambers, A. F. (2008b). Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res. 10, R62.
23. Ruan, K., Bao, S., and Ouyang, G. (2009). The multifaceted role of periostin in tumorigenesis. Cell Mol. Life Sci. 66, 2219-2230.
24. Shao, L., Cui, Y., Li, H., Liu, Y., Zhao, H., Wang, Y., Zhang, Y., Ng, K. M., Han, W., Ma, D., et al. (2007). CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin. Cancer Res. 13, 5756-5762. (Pubitemid 47583900)
25. Shivapurkar, N., Toyooka, S., Toyooka, K. O., Reddy, J., Miyajima, K., Suzuki, M., Shigematsu, H., Takahashi, T., Parikh, G., Pass, H. I., et al. (2004). Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int. J. Cancer 109, 786-792. (Pubitemid 38405630)
26. Sohn, B. H., Park, I. Y., Lee, J. J., Yang, S. J., Jang, Y. J., Park, K. C., Kim, D. J., Lee, D. C., Sohn, H. A., Kim, T. W., et al. (2010). Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology 138, 1898-1908.
27. Tommasi, S., Karm, D. L., Wu, X., Yen, Y., and Pfeifer, G. P. (2009). Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res. 11, R14.
28. Van der Auwera, I., Yu, W., Suo, L., Van Neste, L., van Dam, P., Van Marck, E. A., Pauwels, P., Vermeulen, P. B., Dirix, L. Y., and Van Laere, S. J. (2010). Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 5, e12616.
29. van Horssen, R., Ten Hagen, T. L., and Eggermont, A. M. (2006). TNF-αlpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11, 397-408.
30. Weng, W., Yang, Q., Huang, M., Qiao, Y., Xie, Y., Yu, Y., jing, A., and Li, Z. (2011). c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochem. Biophys. Res. Commun. 405, 278-284.
31. Wolf, I., O'Kelly, J., Rubinek, T., Tong, M., Nguyen, A., Lin, B., Tai, H., Karlan, B., and Koeffler, H. (2006). 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res. 66, 7818-7823. (Pubitemid 44289243)
32. Xiong, J., and Epstein, R. J. (2009). Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status. Mol. Cancer Ther. 8, 779-785.
33. Xiong, H., Qiu, H., Zhuang, L., Jiang, R., and Chen, Y. (2009). Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29, 498-502.
34. Yan, P. S., Shi, H., Rahmatpanah, F., Hsiau, T. H., Hsiau, A. H., Leu, Y. W., Liu, J. C., and Huang, T. H. (2003). Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res. 63, 6178-6186. (Pubitemid 37255161)
35. Yin, Y., Chen, X., and Shu, Y. (2009). Gene expression of the invasive phenotype of TNF-αlpha-treated MCF-7 cells. Biomed. Pharmacother. 63, 421-428.
36. Zhang, Q., Wang, H. Y., Bhutani, G., Liu, X., Paessler, M., Tobias, J. W., Baldwin, D., Swaminathan, K., Milone, M. C. and Wasik, M. A., (2009). Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis. Proc. Natl. Acad. Sci. USA 106, 15843-15848.
37. Zhang, Y., Zhang, G., Li, J., Tao, Q., and Tang, W. (2010). The expression analysis of periostin in human breast cancer. J. Surg. Res. 160, 102-106.